The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis ...

Top health officials were aware of and actively took steps to “delay warning the public” for months in 2021 about the potential risks of patients suffering from heart-related ...

Cardiovascular issues are common, and now some experts term severe COVID an independent coronary artery disease risk factor ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

Federal health agencies were alerted in February 2021 to "large reports of myocarditis" in young people who received the ...

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from ...

Adults who later developed long COVID had lower cardiorespiratory fitness (CRF) before infection than those who did not.